LABORATORY CONTROL OF ANTICOAGULANT PROPHYLAXIS IN PREGNANT WOMEN WITH CARDIOVASCULAR DISEASES
Abstract
This article examines the effect of anticoagulant prophylaxis on pregnancy, childbirth and the postpartum period in women with heart disease. Тhe main mechanisms of formation of side effects from anticoagulant prophylaxis in pregnant women with diseases of the cardiovascular system were studied by means of laboratory research methods,. Have been studied the effects and interaction of different types of anticoagulant prophylaxis and aspirin prophylaxis on primary hemostasis. An algorithm for diagnosing the negative effect of anticoagulants on platelets has been developed. The study examines the possibility of drug correction of the development of side effects from anticoagulant thromboprophylaxis for women with diseases of the cardiovascular system.
References
RCOG. Green-top Guideline No. 37a (April 2015). Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Great Britain.
https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-37a.pdf
Bates S. et al. (2012) American College of Chest Physicians. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: Chest. 2012 Feb;141(2 Suppl):e691S-e736S. doi: 10.1378/chest.11-2300.
Watson H, Davidson S and Keeling D (2012) Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. Guidelines on the diagnosis and management of heparin-induced thrombocytopenia: second edition. Br J Haematol. 2012 Dec;159(5):528-40. doi: 10.1111/bjh.12059. Epub 2012 Oct 9.
Centre for Maternal and Child Enquiries (CMACE). Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–08. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011 Apr;66(4):243-6. doi: 10.1111/j.1365-2044.2011.06689.x. Epub 2011 Mar 2.
Samama C et al. (2006); Committee for Good Practice Standards of the French Society for Anaesthesiology and Intensive Care (SFAR). Venous thromboembolism prevention in surgery and obstetrics: clinical practice guidelines. Eur J Anaesthesiol . 2006 Feb;23(2):95-116. doi: 10.1017/S0265021505002164.
Vera Regitz-Zagrosek et al. (2018) 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy: The Task Force for the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) European Heart Journal, Volume 39, Issue 34, 07 September 2018, Pages 3165–3241,
https://doi.org/10.1093/eurheartj/ehy340
European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.
Farm M et al. (2017) Evaluation of a diagnostic algorithm for Heparin-Induced Thrombocytopenia. Thromb Res. 2017 Apr;152:77-81. doi: 10.1016/j.thromres.2017.02.015. Epub 2017 Feb 24.
Liederman Z, et al. (2019) Heparin-induced thrombocytopenia: An international assessment of the quality of labor testing. J Thromb Haemost. 2019 Dec;17(12):2123-2130. doi: 10.1111/jth.14611. Epub 2019 Sep 25.
Gowthami M. Arepally (2017) Heparin-induced thrombocytopenia. J Blood (2017) 129 (21): 2864–2872.
Views:
152
Downloads:
147
Copyright (c) 2021 Vladimir Medved, Taras Savka
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
